• Users Online: 86
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 10  |  Issue : 3  |  Page : 87-90

Study of bone markers in hyperthyroidism: Single center experience from South India


1 Department of Endocrinology, Krishna Institute of Medical Sciences, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
2 Department of Biochemistry, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
3 Department of Endocrinology, Osmania General Hospital, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India
4 Department of Endocrinology, Care Hospital, Hyderabad, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India

Correspondence Address:
Babulreddy Hanmayyagari
Flat No. A 904, Sri Sai Ram Towers, Beside Alwyn Colony Water Tank, Hafeezpet, Hyderabad - 500 049, Telangana
India
Login to access the Email id


DOI: 10.4103/1858-5000.167867

Rights and Permissions

Aim: To evaluate bone health markers and Vitamin D status in patients with hyperthyroidism comprehensively, and comparison of same with matched controls. Materials and Methods: The study has been done on 30 newly diagnosed hyperthyroid patients and matched controls. Cases were selected after careful exclusion of conditions which adversely affect bone health. Statistical comparisons were performed with Student's t-test. Results: The study group has shown normal calcium (20% had hypocalcemia), normal phosphorus, normal parathyroid hormone values, raised alkaline phosphatase levels, and significant rise in both bone formation (osteocalcin) and resorption (β-cross laps) markers (P < 0.05). In addition, 95% of our subjects (patients and controls) were Vitamin D deficient (mean - 17.2 ng/dl). Conclusion: Hyperthyroidism is associated with increased rate of bone remodeling and changes in mineral homeostasis, thereby increases fracture risk. Associated Vitamin D deficiency further deteriorates bone quality. Hence, we suggest therapeutic Vitamin D and calcium supplementation is needed in addition to antithyroid medication.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed632    
    Printed30    
    Emailed0    
    PDF Downloaded105    
    Comments [Add]    

Recommend this journal